Garcinia cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation

World Journal of Gastroenterology

Volumn 19, Issue 29, 2013, Pages 4689-4701

  Kim, Young Je ^a   Choi, Myung Sook ^a   Park, Yong Bok ^a   Kim, Sang Ryong ^a   Lee, Mi Kyung ^b   Jung, Un Ju ^a  

^a Kyungpook National University   (South Korea)

^b Sunchon National University   (South Korea)

Author keywords

Anti adiposity; Garcinia cambogia; Hepatic collagen accumulation; Hepatic inflammation; Hepatic oxidative stress; Metabolic changes

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN; ASPARTATE AMINOTRANSFERASE; COLLAGEN; FATTY ACID SYNTHASE; GLUCOSE; GLUTATHIONE PEROXIDASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FATTY ACID OXIDATION; GARCINIA CAMBOGIA; GENE EXPRESSION; INFLAMMATION; LIPID DIET; LIPID PEROXIDATION; LIPID STORAGE; LIVER HISTOLOGY; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION;

EID: 84881056731     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i29.4689     Document Type: Article

References (70)

1. Gallagher EJ, Leroith D, Karnieli E. Insulin resistance inobesity as the underlying cause for the metabolic syndrome. Mt Sinai J Med 2010; 77: 511-523 [PMID: 20960553 DOI: 10.1002/msj.20212]
2. World Health Organization. Global Strategy on Diet, Physical Activity and Health. Available from: URL: http://www.who.int/dietphysicalactivity/media/en/gsfs_obesity.pdf
3. Pillitteri JL, Shiffman S, Rohay JM, Harkins AM, Burton SL, Wadden TA. Use of dietary supplements for weight loss in the United States: results of a national survey. Obesity (Silver Spring) 2008; 16: 790-796 [PMID: 18239570 DOI: 10.1038/ oby.2007.136]
4. Pittler MH, Schmidt K, Ernst E. Adverse events of herbal food supplements for body weight reduction: systematic review. Obes Rev 2005; 6: 93-111 [PMID: 15836459 DOI: 10.1111/j.1467-789X.2005.00169.x]
5. Hurt RT, Wilson T. Geriatric obesity: evaluating the evidence for the use of flavonoids to promote weight loss. J Nutr Gerontol Geriatr 2012; 31: 269-289 [PMID: 22888842 DOI: 10.1080/21551197.2012.698222]
6. Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA 1998; 280: 1596-1600 [PMID: 9820262 DOI: 10.1001/ jama.280.18.1596]
7. Leonhardt M, Hrupka B, Langhans W. Effect of hydroxycitrate on food intake and body weight regain after a period of restrictive feeding in male rats. Physiol Behav 2001; 74: 191-196 [PMID: 11564468 DOI: 10.1016/S0031-9384(01)00547-9]
8. Sullivan AC, Triscari J, Neal MO. The influence of (-)-hydroxycitrate on in vivo rates of hepatic glycogenesis: lipogenesis and cholesterol-genesis. Fed Proc 1974; 33: 656
9. Nageswara RR, Sakeriak KK. Lipid-lowering and antiobesity effect of (-) hydroxycitric acid. Nutr Res 1988; 8: 209-212 [DOI: 10.1016/S0271-5317(88)80024-1]
10. Márquez F, Babio N, Bulló M, Salas-Salvadó J. Evaluation of the safety and efficacy of hydroxycitric acid or Garcinia cambogia extracts in humans. Crit Rev Food Sci Nutr 2012; 52: 585-594 [PMID: 22530711 DOI: 10.1080/10408398.2010.50055 1]
11. Kim KY, Lee HN, Kim YJ, Park T. Garcinia cambogia extract ameliorates visceral adiposity in C57BL/6J mice fed on a high-fat diet. Biosci Biotechnol Biochem 2008; 72: 1772-1780 [PMID: 18603810 DOI: 10.1271/bbb.80072]
12. Saito M, Ueno M, Ogino S, Kubo K, Nagata J, Takeuchi M. High dose of Garcinia cambogia is effective in suppressing fat accumulation in developing male Zucker obese rats, but highly toxic to the testis. Food Chem Toxicol 2005; 43: 411-419 [PMID: 15680676 DOI: 10.1016/j.fct.2004.11.008]
13. Hayamizu K, Hirakawa H, Oikawa D, Nakanishi T, Takagi T, Tachibana T, Furuse M. Effect of Garcinia cambogia extract on serum leptin and insulin in mice. Fitoterapia 2003; 74: 267-273 [PMID: 12727492 DOI: 10.1016/S0367- 326X(03)00036-4]
14. Stevens T, Qadri A, Zein NN. Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut. Ann Intern Med 2005; 142: 477-478 [PMID: 15767636 DOI: 10.7326/0003-4819-142-6-200503150-00026]
15. Dara L, Hewett J, Lim JK. Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements. World J Gastroenterol 2008; 14: 6999-7004 [PMID: 19058338 DOI: 10.3748/wjg.14.6999]
16. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497-509 [PMID: 13428781]
17. Kim HJ, Lee KT, Park YB, Jeon SM, Choi MS. Dietary docosahexaenoic acid-rich diacylglycerols ameliorate hepatic steatosis and alter hepatic gene expressions in C57BL/6JLep(ob/ob) mice. Mol Nutr Food Res 2008; 52: 965-973 [PMID: 18481331 DOI: 10.1002/mnfr.200700315]
18. Carl MN, Lakshmanan MR, Porter JW. Fatty acid synthase from rat liver. Methods In Enzymology 1975; 35: 37-44 [DOI: 10.1016/0076-6879(75)35136-7]
19. Markwell MA, McGroarty EJ, Bieber LL, Tolbert NE. The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. A new peroxisomal enzyme. J Biol Chem 1973; 248: 3426-3432 [PMID: 4702872]
20. Lazarow PB. Assay of peroxisomal beta-oxidation of fatty acids. Methods Enzymol 1981; 72: 315-319 [PMID: 7031421 DOI: 10.1016/S0076-6879(81)72021-4]
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254 [PMID: 942051 DOI: 10.1016/0003-2697(76)90527-3]
22. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358 [PMID: 36810 DOI: 10.1016/0003-2697(79)9 0738-3]
23. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-1108 [PMID: 18546601]
24. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, Janssen I. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000; 133: 92-103 [PMID: 10896648 DOI: 10.7326/ 0003-4819-133-2-200007180-00008]
25. Blackburn GL. Treatment approaches: food first for weight management and health. Obes Res 2001; 9 Suppl 4: 223S-227S [PMID: 11707545 DOI: 10.1038/oby.2001.122]
26. Scaglioni F, Marino M, Ciccia S, Procaccini A, Busacchi M, Loria P, Lonardo A, Malavolti M, Battistini NC, Pellegrini M, Carubbi F, Bellentani S. Short-term multidisciplinary nonpharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD). Clin Res Hepatol Gastroenterol 2012; Epub ahead of print [PMID: 23273500]
27. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53: 372-384 [PMID: 20494470 DOI: 10.1016/j.jhep.2010.04.008]
28. Farrell GC, Chitturi S, Lau GK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22: 775-777 [PMID: 17565629 DOI: 10.1111/j.1440-1746.2007.05002.x]
29. Fan JG, Jia JD, Li YM, Wang BY, Lu LG, Shi JP, Chan LY. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease. J Dig Dis 2011; 12: 38-44 [PMID: 21276207 DOI: 10.1111/j.1751-2980.2010.00476.x]
30. Loria P, Adinolfi LE, Bellentani S, Bugianesi E, Grieco A, Fargion S, Gasbarrini A, Loguercio C, Lonardo A, Marchesini G, Marra F, Persico M, Prati D, Baroni GS. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010; 42: 272-282 [PMID: 20171943 DOI: 10.1016/ j.dld.2010.01.021]
31. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-1609 [PMID: 22656328 DOI: 10.1053/ j.gastro.2012.04.001]
32. Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, Durmaz O, Lacaille F, McLin V, Nobili V. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 2012; 54: 700-713 [PMID: 22395188 DOI: 10.1097/MPG.0b013e318252a13f]
33. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012; 3: CD007176 [PMID: 22419320 DOI: 10.1002/14651858.CD007176.pub2]
34. Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr 2004; 79: 529-536 [PMID: 15051593]
35. Lee JY, Hashizaki H, Goto T, Sakamoto T, Takahashi N, Kawada T. Activation of peroxisome proliferator-activated receptor-α enhances fatty acid oxidation in human adipocytes. Biochem Biophys Res Commun 2011; 407: 818-822 [PMID: 21443859 DOI: 10.1016/j.bbrc.2011.03.106]
36. Goto T, Lee JY, Teraminami A, Kim YI, Hirai S, Uemura T, Inoue H, Takahashi N, Kawada T. Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. J Lipid Res 2011; 52: 873-884 [PMID: 21324916 DOI: 10.1194/jlr.M011320]
37. Sullivan AC, Singh M, Srere PA, Glusker JP. Reactivity and inhibitor potential of hydroxycitrate isomers with citrate synthase, citrate lyase, and ATP citrate lyase. J Biol Chem 1977; 252: 7583-7590 [PMID: 334761]
38. McGarry JD, Mannaerts GP, Foster DW. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 1977; 60: 265-270 [PMID: 874089 DOI: 10.1172/JCI108764]
39. Ishihara K, Oyaizu S, Onuki K, Lim K, Fushiki T. Chronic (-)-hydroxycitrate administration spares carbohydrate utilization and promotes lipid oxidation during exercise in mice. J Nutr 2000; 130: 2990-2995 [PMID: 11110858]
40. Asghar M, Monjok E, Kouamou G, Ohia SE, Bagchi D, Lokhandwala MF. Super CitriMax (HCA-SX) attenuates increases in oxidative stress, inflammation, insulin resistance, and body weight in developing obese Zucker rats. Mol Cell Biochem 2007; 304: 93-99 [PMID: 17503004 DOI: 10.1007/ s11010-007-9489-3]
41. Cheng IS, Huang SW, Lu HC, Wu CL, Chu YC, Lee SD, Huang CY, Kuo CH. Oral hydroxycitrate supplementation enhances glycogen synthesis in exercised human skeletal muscle. Br J Nutr 2012; 107: 1048-1055 [PMID: 21824444 DOI: 10.1017/S0007114511003862]
42. Soni MG, Burdock GA, Preuss HG, Stohs SJ, Ohia SE, Bagchi D. Safety assessment of (-)-hydroxycitric acid and Super CitriMax, a novel calcium/potassium salt. Food Chem Toxicol 2004; 42: 1513-1529 [PMID: 15234082 DOI: 10.1016/ j.fct.2004.04.014]
43. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312 [PMID: 11201732 DOI: 10.1038/35053000]
44. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, Scherer PE, Rossetti L. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 2004; 114: 232-239 [PMID: 15254590]
45. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA. Regulation of fasted blood glucose by resistin. Science 2004; 303: 1195-1198 [PMID: 14976316 DOI: 10.1126/science.1092341]
46. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 2003; 111: 225-230 [PMID: 12531878]
47. Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner AE, Cushman SW, Periwal V. Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth. PLoS Comput Biol 2009; 5: e1000324 [PMID: 19325873 DOI: 10.1371/journal. pcbi.1000324]
48. Tripathy D, Almgren P, Tuomi T, Groop L. Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity. Diabetes Care 2004; 27: 2204-2210 [PMID: 15333485 DOI: 10.2337/ diacare.27.9.2204]
49. Ferrara CM, Goldberg AP. Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance. Diabetes Care 2001; 24: 245-249 [PMID: 11213873 DOI: 10.2337/diacare.24.2.245]
50. Pickens MK, Yan JS, Ng RK, Ogata H, Grenert JP, Beysen C, Turner SM, Maher JJ. Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis. J Lipid Res 2009; 50: 2072-2082 [PMID: 19295183 DOI: 10.1194/jlr.M900022-JLR200]
51. Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J, Green RM. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res 2008; 49: 1068-1076 [PMID: 18227531 DOI: 10.1194/jlr.M800042- JLR200]
52. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-1669 [PMID: 18471545 DOI: 10.1016/ j.bpg.2011.02.005]
53. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009; 29: 313-326 [PMID: 19441883 DOI: 10.1089/jir.2008.0027]
54. Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, van Rooijen N, Schwabe RF, Brenner DA. CCR2 promotes hepatic fibrosis in mice. Hepatology 2009; 50: 185-197 [PMID: 19441102 DOI: 10.1002/hep.22952]
55. Ramm GA, Shepherd RW, Hoskins AC, Greco SA, Ney AD, Pereira TN, Bridle KR, Doecke JD, Meikle PJ, Turlin B, Lewindon PJ. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment. Hepatology 2009; 49: 533-544 [PMID: 19115220 DOI: 10.1002/ hep.22637]
56. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210 [PMID: 18161745]
57. Haukeland JW, Damås JK, Konopski Z, Løberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjøro K, Aukrust P. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 2006; 44: 1167-1174 [PMID: 16618517 DOI: 10.1016/j.jhep.2006.02.011]
58. Westerbacka J, Kolak M, Kiviluoto T, Arkkila P, Sirén J, Hamsten A, Fisher RM, Yki-Järvinen H. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/ macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 2007; 56: 2759-2765 [PMID: 17704301 DOI: 10.2337/ db07-0156]
59. Marsillach J, Oliveras-Ferraros C, Beltrán R, Rull A, Aragonès G, Alonso-Villaverde C, Vázquez-Martín A, Joven J, Menéndez JA, Camps J. Serum concentrations of extracellular fatty acid synthase in patients with steatohepatitis. Clin Chem Lab Med 2009; 47: 1097-1099 [PMID: 19728851 DOI: 10.1515/CCLM.2009.259]
60. Greco D, Kotronen A, Westerbacka J, Puig O, Arkkila P, Kiviluoto T, Laitinen S, Kolak M, Fisher RM, Hamsten A, Auvinen P, Yki-Järvinen H. Gene expression in human NAFLD. Am J Physiol Gastrointest Liver Physiol 2008; 294: G1281-G1287 [PMID: 18388185 DOI: 10.1152/ajpgi. 00074.2008]
61. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006; 116: 1494-1505 [PMID: 16691291 DOI: 10.1172/JCI26498]
62. Rull A, Rodríguez F, Aragonès G, Marsillach J, Beltrán R, Alonso-Villaverde C, Camps J, Joven J. Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis. Cytokine 2009; 48: 273-279 [PMID: 19748796 DOI: 10.1016/j.cyto.2009.08.006]
63. Rinella ME, Green RM. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol 2004; 40: 47-51 [PMID: 14672613]
64. Miura K, Yang L, van Rooijen N, Ohnishi H, Seki E. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol 2012; 302: G1310-G1321 [PMID: 22442158 DOI: 10.1152/ajpgi.00365.2011]
65. Ito M, Suzuki J, Tsujioka S, Sasaki M, Gomori A, Shirakura T, Hirose H, Ito M, Ishihara A, Iwaasa H, Kanatani A. Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet. Hepatol Res 2007; 37: 50-57 [PMID: 17300698 DOI: 10.1111/j.1872-034X.2007.00008.x]
66. Kassel KM, Guo GL, Tawfik O, Luyendyk JP. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-cholinedeficient diet. Lab Invest 2010; 90: 1794-1804 [PMID: 20697377 DOI: 10.1038/labinvest.2010.143]
67. Shim M, Saab S. Severe hepatotoxicity due to Hydroxycut: a case report. Dig Dis Sci 2009; 54: 406-408 [PMID: 18661239 DOI: 10.1007/s10620-008-0353-4]
68. Jones FJ, Andrews AH. Acute liver injury associated with the herbal supplement hydroxycut in a soldier deployed to Iraq. Am J Gastroenterol 2007; 102: 2357-2358 [PMID: 17897352 DOI: 10.1111/j.1572-0241.2007.01353_10.x]
69. Sánchez-Valle V, Chávez-Tapia NC, Uribe M, Méndez-Sánchez N. Role of oxidative stress and molecular changes in liver fibrosis: a review. Curr Med Chem 2012; 19: 4850-4860 [PMID: 22709007 DOI: 10.2174/092986712803341520]
70. Galli A, Svegliati-Baroni G, Ceni E, Milani S, Ridolfi F, Salzano R, Tarocchi M, Grappone C, Pellegrini G, Benedetti A, Surrenti C, Casini A. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2- mediated mechanism. Hepatology 2005; 41: 1074-1084 [PMID: 15841469 DOI: 10.1002/hep.20683]